# Oral Sedation in Vitreoretinal Surgery

> **NCT04346095** · PHASE4 · UNKNOWN · sponsor: **Rocky Vista University, LLC** · enrollment: 80 (estimated)

## Conditions studied

- Macular Holes
- Intraocular Lens Opacification
- Vitrectomy
- Vitreous Hemorrhage
- Retinal Detachment
- Epiretinal Membrane
- Vitreous Detachment
- Intraocular Lens Dislocation

## Interventions

- **DRUG:** Oral Sedatives with or Without Analgesia
- **DRUG:** Intravenous Sedatives with or Without Analgesia

## Key facts

- **NCT ID:** NCT04346095
- **Lead sponsor:** Rocky Vista University, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06
- **Primary completion:** 2020-10
- **Final completion:** 2020-11
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2020-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04346095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04346095, "Oral Sedation in Vitreoretinal Surgery". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04346095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*